Dalman's laboratory has received continuous research funding from the National Institutes of Health since 1999, and collaborates with leading investigators in AAA disease worldwide. Dalman's research laboratory studies the pathophysiology of abdominal aortic aneurysm (AAA) disease, a leading cause of death in developed and developing countries worldwide, and is actively engaged in identifying and validating new treatment measures for AAA. Prior to his appointment as Chief of Vascular Surgery at Stanford Health Care, Dalman served as Chief of Vascular Surgery at the Veterans Affairs Palo Alto Health Care System for 14 years. Dalman is a Steering Committee and founding member of the Cardiovascular Institute (CVI). At Stanford Health Care he serves as Co-Director for the Cardiovascular Service Line. He is a member of the Vascular Surgery Board, American Board of Surgery, and a past member of the Residency Review Committee for Surgery, ACGME. His clinical interests include management of aortic diseases and lower extremity circulatory disorders, including limb salvage. He currently holds the Chidester Professorship in the Department of Surgery. Dalman has served as a faculty member of Stanford Surgery since 1992, and directed the Vascular Surgery program from 2005 to 2021. Vice Provost for Undergraduate Educationĭr.
Office of Vice President for Business Affairs and Chief Financial Officer.Office of VP for University Human Resources.
Stanford Woods Institute for the Environment.Stanford Institute for Economic Policy Research (SIEPR).Institute for Stem Cell Biology and Regenerative Medicine.Institute for Human-Centered Artificial Intelligence (HAI).Institute for Computational and Mathematical Engineering (ICME).Freeman Spogli Institute for International Studies.
0 kommentar(er)
